Natrunix

BIOLOGICAL2 trials

Sponsors

XBiotech, Inc.

Conditions

PharmacokineticsRheumatoid Arthritis

Phase 1

Safety and Pharmacokinetics (PK) Study of Natrunix in Healthy Volunteers

CompletedNCT05099510

XBiotech, Inc.Pharmacokinetics

Start: 2022-01-19End: 2022-08-08Updated: 2026-08-14

Phase 2

Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis

CompletedNCT05363891

XBiotech, Inc.Rheumatoid Arthritis

Start: 2023-08-08End: 2024-10-31Updated: 2025-01-16